SLS Stock Analysis: Buy, Sell, or Hold?
SLS - SELLAS Life Sciences Group, Inc. Common Stock
$5.28
-0.26 (-4.69%)
▼
5d:
+7.32%
30d:
+26.92%
90d:
+279.86%
HOLD
MODERATE Confidence
Analysis Updated: Mar 5, 2026 12:00 AM ET
Earnings: Mar 19, 2026
12d
Smart Money Accumulation
SLS is down 3.8% this week, but smart money is accumulating calls. Top strike: $3.5 2026-04-17 with 44,988 OI. Call ratio: 99% View Scanner →
Strength: 6.7/10
Get Alerted When SLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
83 traders called SLS this week
94% bullish • 8 bearish
94% bullish • 8 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SLS is 9.8% above fair value ($4.81). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SLS is 9.8% above fair value ($4.81). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SLS is currently trading at $5.28, which is considered extended relative to its 30-day fair value range of $3.64 to $4.81.
Technical Outlook: Technically, SLS is in a strong uptrend. Immediate support is located at $3.97, while resistance sits at $5.66. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: SLS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.83 (+23.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLS is in a strong uptrend. Immediate support is located at $3.97, while resistance sits at $5.66. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: SLS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.83 (+23.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$3.64 -
$4.81
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding SLS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.8% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 23.3% below Wall St target ($6.83)
Fair Price Analysis
30-Day Fair Range
$3.64 -
$4.81
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$3.97
Resistance Level
$5.66
Current Trend
Strong Uptrend
Technical data as of
Mar 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.49
Wall Street Target
$6.83
(+23.3%)
Revenue Growth (YoY)
-82.5%
Share & Embed Analysis
Last updated: March 06, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
Data refreshes hourly during market hours. Next update: 6:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Katherine Bach Kalin
BUY
63400 shares
2025-11-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$457 | 59 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$531 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 52 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$283 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$92 | 42 HOLD |
Advanced SLS Option Strategies
Professional options setups generated by AI based on today's SLS price and gamma walls.
